This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, L. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2001, p. 5082-5093, Vol. 21, No. 15
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.15.5082-5093.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Identification of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 as Signaling Intermediates in the alpha 6beta 4 Integrin-Dependent Activation of Phosphoinositide 3-OH Kinase and Promotion of Invasion

Leslie M. Shaw*

Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215

Received 17 November 2000/Returned for modification 16 January 2001/Accepted 30 April 2001

Expression of the alpha 6beta 4 integrin increases the invasive potential of carcinoma cells by a mechanism that involves activation of phosphoinositide 3-OH kinase (PI3K). In the present study, we investigated the signaling pathway by which the alpha 6beta 4 integrin activates PI3K. Neither the alpha 6 nor the beta 4 cytoplasmic domain contains the consensus binding motif for PI3K, pYMXM, indicating that additional proteins are likely to be involved in the activation of this lipid kinase by the alpha 6beta 4 integrin. We identified insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the activation of PI3K by the alpha 6beta 4 integrin. IRS-1 and IRS-2 are cytoplasmic adapter proteins that do not contain intrinsic kinase activity but rather function by recruiting proteins to surface receptors, where they organize signaling complexes. Ligation of the alpha 6beta 4 receptor promotes tyrosine phosphorylation of IRS-1 and IRS-2 and increases their association with PI3K, as determined by coimmunoprecipitation. Moreover, we identified a tyrosine residue in the cytoplasmic domain of the beta 4 subunit, Y1494, that is required for alpha 6beta 4-dependent phosphorylation of IRS-2 and activation of PI3K in response to receptor ligation. Most importantly, Y1494 is essential for the ability of the alpha 6beta 4 integrin to promote carcinoma invasion. Taken together, these results imply a key role for the IRS proteins in the alpha 6beta 4-dependent promotion of carcinoma invasion.


* Mailing address: Department of Pathology, Beth Israel Deaconess Medical Center-RN227, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-1430. Fax: (617) 667-3616. E-mail: lshaw{at}caregroup.harvard.edu.


Molecular and Cellular Biology, August 2001, p. 5082-5093, Vol. 21, No. 15
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.15.5082-5093.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kim, T. H., Kim, H. I., Soung, Y. H., Shaw, L. A., Chung, J. (2009). Integrin ({alpha}6{beta}4) Signals Through Src to Increase Expression of S100A4, a Metastasis-Promoting Factor: Implications for Cancer Cell Invasion. Mol Cancer Res 7: 1605-1612 [Abstract] [Full Text]  
  • Al-Mahmood, S., Colin, S., Farhat, N., Thorin, E., Steverlynck, C., Chemtob, S. (2009). Potent in Vivo Antiangiogenic Effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an Antisense Oligonucleotide Preventing the Expression of Insulin Receptor Substrate-1. J. Pharmacol. Exp. Ther. 329: 496-504 [Abstract] [Full Text]  
  • Hanke, S., Mann, M. (2009). The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2. Mol. Cell. Proteomics 8: 519-534 [Abstract] [Full Text]  
  • Thorn, C C, Freeman, T C, Scott, N, Guillou, P J, Jayne, D G (2009). Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype. Gut 58: 404-412 [Abstract] [Full Text]  
  • Gilcrease, M. Z., Kilpatrick, S. K., Woodward, W. A., Zhou, X., Nicolas, M. M., Corley, L. J., Fuller, G. N., Tucker, S. L., Diaz, L. K., Buchholz, T. A., Frost, J. A. (2009). Coexpression of {alpha}6{beta}4 Integrin and Guanine Nucleotide Exchange Factor Net1 Identifies Node-Positive Breast Cancer Patients at High Risk for Distant Metastasis. Cancer Epidemiol. Biomarkers Prev. 18: 80-86 [Abstract] [Full Text]  
  • Szabolcs, M., Keniry, M., Simpson, L., Reid, L. J., Koujak, S., Schiff, S. C., Davidian, G., Licata, S., Gruvberger-Saal, S., Murty, V. V.V.S., Nandula, S., Efstratiadis, A., Kushner, J. A., White, M. F., Parsons, R. (2009). Irs2 Inactivation Suppresses Tumor Progression in Pten+/- Mice. Am. J. Pathol. 174: 276-286 [Abstract] [Full Text]  
  • Dutta, U., Shaw, L. M. (2008). A Key Tyrosine (Y1494) in the {beta}4 Integrin Regulates Multiple Signaling Pathways Important for Tumor Development and Progression. Cancer Res. 68: 8779-8787 [Abstract] [Full Text]  
  • Kim, H. I., Huang, H., Cheepala, S., Huang, S., Chung, J. (2008). Curcumin Inhibition of Integrin ({alpha}6{beta}4)-Dependent Breast Cancer Cell Motility and Invasion. Cancer Prevention Research 1: 385-391 [Abstract] [Full Text]  
  • Folgiero, V., Bachelder, R. E., Bon, G., Sacchi, A., Falcioni, R., Mercurio, A. M. (2007). The {alpha}6{beta}4 Integrin Can Regulate ErbB-3 Expression: Implications for {alpha}6{beta}4 Signaling and Function. Cancer Res. 67: 1645-1652 [Abstract] [Full Text]  
  • Bertotti, A., Comoglio, P. M., Trusolino, L. (2006). {beta}4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth. JCB 175: 993-1003 [Abstract] [Full Text]  
  • Dearth, R. K., Cui, X., Kim, H.-J., Kuiatse, I., Lawrence, N. A., Zhang, X., Divisova, J., Britton, O. L., Mohsin, S., Allred, D. C., Hadsell, D. L., Lee, A. V. (2006). Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2. Mol. Cell. Biol. 26: 9302-9314 [Abstract] [Full Text]  
  • Ma, Z., Gibson, S. L., Byrne, M. A., Zhang, J., White, M. F., Shaw, L. M. (2006). Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis. Mol. Cell. Biol. 26: 9338-9351 [Abstract] [Full Text]  
  • Pullar, C. E., Baier, B. S., Kariya, Y., Russell, A. J., Horst, B. A.J., Marinkovich, M. P., Isseroff, R. R. (2006). beta4 Integrin and Epidermal Growth Factor Coordinately Regulate Electric Field-mediated Directional Migration via Rac1. Mol. Biol. Cell 17: 4925-4935 [Abstract] [Full Text]  
  • Cui, X., Kim, H.-J., Kuiatse, I., Kim, H., Brown, P. H., Lee, A. V. (2006). Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration.. Cancer Res. 66: 5304-5313 [Abstract] [Full Text]  
  • Kalfa, N., Ecochard, A., Patte, C., Duvillard, P., Audran, F., Pienkowski, C., Thibaud, E., Brauner, R., Lecointre, C., Plantaz, D., Guedj, A.-M., Paris, F., Baldet, P., Lumbroso, S., Sultan, C. (2006). Activating Mutations of the Stimulatory G Protein in Juvenile Ovarian Granulosa Cell Tumors: A New Prognostic Factor?. J. Clin. Endocrinol. Metab. 91: 1842-1847 [Abstract] [Full Text]  
  • Wilhelmsen, K., Litjens, S. H.M., Sonnenberg, A. (2006). Multiple Functions of the Integrin {alpha}6{beta}4 in Epidermal Homeostasis and Tumorigenesis. Mol. Cell. Biol. 26: 2877-2886 [Full Text]  
  • Fukumoto, S., Miner, J. H., Ida, H., Fukumoto, E., Yuasa, K., Miyazaki, H., Hoffman, M. P., Yamada, Y. (2006). Laminin {alpha}5 Is Required for Dental Epithelium Growth and Polarity and the Development of Tooth Bud and Shape. J. Biol. Chem. 281: 5008-5016 [Abstract] [Full Text]  
  • Bertotti, A., Comoglio, P. M., Trusolino, L. (2005). {beta}4 Integrin Is a Transforming Molecule that Unleashes Met Tyrosine Kinase Tumorigenesis. Cancer Res. 65: 10674-10679 [Abstract] [Full Text]  
  • Berdugo, M., Andrieu-Soler, C., Doat, M., Courtois, Y., BenEzra, D., Behar-Cohen, F. (2005). Downregulation of IRS-1 Expression Causes Inhibition of Corneal Angiogenesis. IOVS 46: 4072-4078 [Abstract] [Full Text]  
  • Vulin, A. I., Jacob, K. K., Stanley, F. M. (2005). Integrin Activates Receptor-Like Protein Tyrosine Phosphatase {alpha}, Src, and Rho to Increase Prolactin Gene Expression through a Final Phosphatidylinositol 3-Kinase/Cytoskeletal Pathway that Is Additive with Insulin. Endocrinology 146: 3535-3546 [Abstract] [Full Text]  
  • Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., Puri, C., Tacchetti, C., Giancotti, F. G. (2005). Targeted Deletion of the Integrin {beta}4 Signaling Domain Suppresses Laminin-5-Dependent Nuclear Entry of Mitogen-Activated Protein Kinases and NF-{kappa}B, Causing Defects in Epidermal Growth and Migration. Mol. Cell. Biol. 25: 6090-6102 [Abstract] [Full Text]  
  • Raymond, K., Kreft, M., Janssen, H., Calafat, J., Sonnenberg, A. (2005). Keratinocytes display normal proliferation, survival and differentiation in conditional {beta}4-integrin knockout mice. J. Cell Sci. 118: 1045-1060 [Abstract] [Full Text]  
  • Nagle, J. A., Ma, Z., Byrne, M. A., White, M. F., Shaw, L. M. (2004). Involvement of Insulin Receptor Substrate 2 in Mammary Tumor Metastasis. Mol. Cell. Biol. 24: 9726-9735 [Abstract] [Full Text]  
  • Chung, J., Yoon, S.-O., Lipscomb, E. A., Mercurio, A. M. (2004). The Met Receptor and {alpha}6{beta}4 Integrin Can Function Independently to Promote Carcinoma Invasion. J. Biol. Chem. 279: 32287-32293 [Abstract] [Full Text]  
  • Neid, M., Datta, K., Stephan, S., Khanna, I., Pal, S., Shaw, L., White, M., Mukhopadhyay, D. (2004). Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells. J. Biol. Chem. 279: 3941-3948 [Abstract] [Full Text]  
  • Diaz, L. K., Zhou, X., Welch, K., Sahin, A., Gilcrease, M. Z. (2004). Chromogenic In Situ Hybridization for {alpha}6{beta}4 Integrin in Breast Cancer: Correlation with Protein Expression. J. Mol. Diagn. 6: 10-15 [Abstract] [Full Text]  
  • Owens, D. M., Romero, M. R., Gardner, C., Watt, F. M. (2003). Suprabasal {alpha}6{beta}4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGF{beta} signalling. J. Cell Sci. 116: 3783-3791 [Abstract] [Full Text]  
  • Lee, A. V., Schiff, R., Cui, X., Sachdev, D., Yee, D., Gilmore, A. P., Streuli, C. H., Oesterreich, S., Hadsell, D. L. (2003). New Mechanisms of Signal Transduction Inhibitor Action: Receptor Tyrosine Kinase Down-Regulation and Blockade of Signal Transactivation. Clin. Cancer Res. 9: 516s-523s [Abstract] [Full Text]  
  • Geuijen, C. A. W., Sonnenberg, A. (2002). Dynamics of the alpha 6beta 4 Integrin in Keratinocytes. Mol. Biol. Cell 13: 3845-3858 [Abstract] [Full Text]  
  • Chung, J., Bachelder, R. E., Lipscomb, E. A., Shaw, L. M., Mercurio, A. M. (2002). Integrin ({alpha}6{beta}4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. JCB 158: 165-174 [Abstract] [Full Text]  
  • Morena, A., Riccioni, S., Marchetti, A., Polcini, A. T., Mercurio, A. M., Blandino, G., Sacchi, A., Falcioni, R. (2002). Expression of the beta 4 integrin subunit induces monocytic differentiation of 32D/v-Abl cells. Blood 100: 96-106 [Abstract] [Full Text]  
  • Mariotti, A., Kedeshian, P. A., Dans, M., Curatola, A. M., Gagnoux-Palacios, L., Giancotti, F. G. (2001). EGF-R signaling through Fyn kinase disrupts the function of integrin {alpha}6{beta}4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. JCB 155: 447-458 [Abstract] [Full Text]